कंपनी का अवलोकन
Avanos Medical, Inc. operates as a specialized medical technology provider delivering device solutions across diverse global regions including North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The enterprise focuses primarily on digestive health products, offering a portfolio that encompasses Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal devices. This entity functions within the Healthcare sector and specifically targets the Medical Devices industry, positioning itself to serve clinical needs for patient nutrition and care. In terms of scale, the company holds a market capitalization of $655.29M and generates annual revenue of $701.20M, while employing a workforce of 2287 individuals. These valuation and revenue figures suggest a mid-cap profile with significant operational reach, indicating a substantial presence in the medical device landscape without reaching the scale of large-cap conglomerates.
वित्तीय स्वास्थ्य
The company reported a revenue of $701.20M over the trailing twelve months, yet recorded a net income of -$72,900,000, revealing a substantial gap where operating costs and expenses significantly eroded profitability. Despite the net loss, the company maintained an EBITDA of $54.40M, which highlights a robust operational cash generation capability before the impact of non-operating charges or interest expenses. The firm generated free cash flow of $46.01M, a metric that underscores strong financial flexibility allowing for potential capital expenditures, debt repayment, or strategic investments without immediate reliance on external financing. Margin analysis shows a gross margin of 50.5%, indicating efficient production and pricing power at the operational level, contrasted by an operating margin of 2.0% and a profit margin of -10.4%. The negative profit margin reflects high fixed costs or significant selling, general, and administrative expenses that outweigh the operating profits. Regarding liquidity, total cash holdings of $89.80M are lower than the total debt of $129.10M, resulting in a debt-to-equity ratio of 16.59, which characterizes the balance sheet as highly leveraged. However, the current ratio stands at 2.15, suggesting that the company maintains a conservative stance on short-term liquidity with current assets sufficient to cover short-term obligations more than twice over. Return on Equity stands at -9.1% and Return on Assets is 0.9%, metrics that indicate management is currently struggling to generate returns for shareholders and utilize assets effectively to drive profit generation.
मूल्यांकन आकलन
Valuation metrics present a mixed picture where the trailing P/E Ratio is listed as N/A due to the net loss, while the forward P/E stands at 11.27, implying that the market expects a significant turnaround in earnings trajectory to justify the current price. The price-to-book ratio is recorded at 0.84, indicating that the stock trades at a discount relative to its book value, suggesting the market values the company's assets conservatively. Alternative valuation measures include a price-to-sales ratio of 0.93 and an EV/EBITDA of 12.77, which provide context for the company's valuation based on revenue multiples and enterprise value relative to earnings power. The stock price has fluctuated between a 52-week low of $9.30 and a 52-week high of $15.68, with the current trading price situated within this historical range. The beta value is 1.05, meaning the stock exhibits a volatility level slightly higher than the broader market, suggesting it will typically move with or slightly more than the general market index.
Growth & Income
Revenue growth year-over-year is recorded at 0.7%, while earnings growth is listed as N/A due to the negative net income, indicating that profitability has not yet expanded in tandem with sales. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it retains all earnings to reinvest into growth initiatives or reduce its substantial debt load rather than distributing income to shareholders. The absence of a dividend policy aligns with the company's need to preserve cash and manage its highly leveraged balance sheet given the debt-to-equity ratio of 16.59. Overall, the growth and income profile is characterized by modest revenue expansion, a lack of current profitability, and a non-dividend strategy focused on operational restructuring and financial deleveraging.